Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 3.06% to $137.92 on Wednesday, underperforming competitors like Eli Lilly and DexCom during a broader market decline. This marks the stock's third consecutive day of losses, with trading volume exceeding its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slid 3.06% to $137.92 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.48% to 7,636.36 and Dow Jones Industrial Average falling 0.77% to 52,380.66.
This was the stock's third consecutive day of losses.
Insulet Corp. closed 61.14% short of its 52-week high of $354.88, which the company reached on November 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Eli Lilly & Co. (LLY) rose 0.03% to $1,124.21, DexCom Inc. (DXCM) fell 0.77% to $83.88, and Johnson & Johnson (JNJ) fell 0.76% to $267.08.
Trading volume (2.1 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-09-26 1716ET